These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis. Carroll MW; Jeon D; Mountz JM; Lee JD; Jeong YJ; Zia N; Lee M; Lee J; Via LE; Lee S; Eum SY; Lee SJ; Goldfeder LC; Cai Y; Jin B; Kim Y; Oh T; Chen RY; Dodd LE; Gu W; Dartois V; Park SK; Kim CT; Barry CE; Cho SN Antimicrob Agents Chemother; 2013 Aug; 57(8):3903-9. PubMed ID: 23733467 [TBL] [Abstract][Full Text] [Related]
3. The management of pulmonary and lymph node tuberculosis notified in England and Wales in 1998. Ormerod LP; Prescott RJ Clin Med (Lond); 2003; 3(1):57-61. PubMed ID: 12617417 [TBL] [Abstract][Full Text] [Related]
4. Elevated Plasma Moxifloxacin Concentrations and Weiner M; Gelfond J; Johnson-Pais TL; Engle M; Peloquin CA; Johnson JL; Sizemore EE; Mac Kenzie WR Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463526 [TBL] [Abstract][Full Text] [Related]
5. Adverse drug reactions in drug resistant pulmonary tuberculosis patients. Tewari S; Patel R; Shah K Indian J Tuberc; 2024; 71 Suppl 1():S25-S28. PubMed ID: 39067950 [TBL] [Abstract][Full Text] [Related]
6. The challenge of discharging research ethics duties in resource-constrained settings. Singh JA PLoS Med; 2011 Mar; 8(3):e1000421. PubMed ID: 21423584 [TBL] [Abstract][Full Text] [Related]
7. The early bactericidal activity of antituberculosis drugs. Diacon AH; Donald PR Expert Rev Anti Infect Ther; 2014 Feb; 12(2):223-37. PubMed ID: 24392698 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolones for the treatment of pulmonary tuberculosis. Moadebi S; Harder CK; Fitzgerald MJ; Elwood KR; Marra F Drugs; 2007; 67(14):2077-99. PubMed ID: 17883288 [TBL] [Abstract][Full Text] [Related]
9. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective]. Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177 [No Abstract] [Full Text] [Related]
10. [The effectiveness and safety of sparfloxacine in combined therapy for tuberculosis]. Sokolova GB; Khaĭmenova TIa; Borisov SE; Lazareva IaV; Bogadel'nikova IV; Biron MG; Mozhokina GN; Tsibanev AA Probl Tuberk Bolezn Legk; 2007; (6):40-5. PubMed ID: 17674470 [TBL] [Abstract][Full Text] [Related]
11. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis]. Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179 [No Abstract] [Full Text] [Related]
12. Efficacy and safety of sparfloxacin in combination with kanamycin and ethionamide in multidrug-resistant pulmonary tuberculosis patients: preliminary results. Singla R; Gupta S; Gupta R; Arora VK Int J Tuberc Lung Dis; 2001 Jun; 5(6):559-63. PubMed ID: 11409584 [TBL] [Abstract][Full Text] [Related]